NCT03351114View on ClinicalTrials.gov

Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea

PHASE2CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

March 10, 2020

Study Completion Date

March 10, 2020

Conditions

Morphea

Interventions

DRUG

Crisaborole

Apply Crisaborole 2% ointment to affected skin twice per day.

Trial Locations (1)

27710

Duke University, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Duke University

OTHER